• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高麻疹、腮腺炎、风疹疫苗接种率人群中的麻疹抗体血清流行率

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population.

作者信息

Quach Huy Quang, Ovsyannikova Inna G, Grill Diane E, Warner Nathaniel D, Poland Gregory A, Kennedy Richard B

机构信息

Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Vaccines (Basel). 2022 Nov 3;10(11):1859. doi: 10.3390/vaccines10111859.

DOI:10.3390/vaccines10111859
PMID:36366367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9698789/
Abstract

As an extremely contagious pathogen, a high rate of vaccine coverage and the durability of vaccine-induced immunity are key factors to control and eliminate measles. Herein, we assessed the seroprevalence of antibodies specific to measles in a cohort of 1393 adults (20-44 years old). ELISA results showed a nontrivial proportion of 37.6% study subjects being negative for measles immunoglobulin G (IgG). We also found significant influences of sex and age of the study cohort on the IgG level. Our findings suggest that even within a highly vaccinated population, a subset of individuals may still have sub-optimal immunity against measles and potentially be susceptible during any future measles outbreaks.

摘要

作为一种极具传染性的病原体,高疫苗接种覆盖率和疫苗诱导免疫的持久性是控制和消除麻疹的关键因素。在此,我们评估了1393名成年人(20 - 44岁)队列中麻疹特异性抗体的血清流行率。酶联免疫吸附测定(ELISA)结果显示,37.6%的研究对象麻疹免疫球蛋白G(IgG)呈阴性,这一比例不容小觑。我们还发现研究队列的性别和年龄对IgG水平有显著影响。我们的研究结果表明,即使在疫苗接种率很高的人群中,仍有一部分个体对麻疹的免疫力可能未达到最佳状态,在未来任何麻疹疫情爆发期间都可能易感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/9698789/e990199f3303/vaccines-10-01859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/9698789/19fd24e2a939/vaccines-10-01859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/9698789/e990199f3303/vaccines-10-01859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/9698789/19fd24e2a939/vaccines-10-01859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/9698789/e990199f3303/vaccines-10-01859-g002.jpg

相似文献

1
Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population.高麻疹、腮腺炎、风疹疫苗接种率人群中的麻疹抗体血清流行率
Vaccines (Basel). 2022 Nov 3;10(11):1859. doi: 10.3390/vaccines10111859.
2
Seroprevalence of IgG antibodies against measles in a selected Polish population - do we need to be re-vaccinated?特定波兰人群中抗麻疹IgG抗体的血清流行率——我们需要重新接种疫苗吗?
Cent Eur J Immunol. 2019;44(4):380-383. doi: 10.5114/ceji.2019.92789. Epub 2020 Jan 20.
3
High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.在中国江苏省幼儿园,2-5 岁儿童接受一剂含腮腺炎疫苗后感染腮腺炎的高风险:腮腺炎免疫力下降。
Hum Vaccin Immunother. 2020 Jul 2;16(7):1738-1742. doi: 10.1080/21645515.2019.1708162. Epub 2020 Jan 24.
4
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.第二剂麻疹-腮腺炎-风疹(MMR)疫苗的免疫原性及其对血清学监测的影响。
Vaccine. 2002 Jan 15;20(7-8):1134-40. doi: 10.1016/s0264-410x(01)00435-2.
5
Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.评估科威特年轻人对麻疹、腮腺炎和风疹的免疫状态:MMR 疫苗的效力。
J Med Virol. 2020 Aug;92(8):963-970. doi: 10.1002/jmv.25665. Epub 2020 Feb 3.
6
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.通过IgG亲和力测定发现的继发性麻疹疫苗接种失败:在幼年接种疫苗的青少年中发生率较高。
Epidemiol Infect. 2000 Apr;124(2):263-71. doi: 10.1017/s0950268899003222.
7
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.儿童时期接种 MMR 疫苗后,年轻人对腮腺炎的体液免疫减弱。
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19071-19076. doi: 10.1073/pnas.1905570116. Epub 2019 Sep 3.
8
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].[1996年麻疹、腮腺炎和风疹抗体的年龄相关血清流行率]
Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57.
9
Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy.意大利成年人群接种疫苗或自然感染麻疹病毒后的血清阳性率
Vaccines (Basel). 2020 Feb 3;8(1):66. doi: 10.3390/vaccines8010066.
10
Seroprevalence and durability of rubella virus antibodies in a highly immunized population.风疹病毒抗体在高度免疫人群中的血清阳性率和持久性。
Vaccine. 2019 Jun 27;37(29):3876-3882. doi: 10.1016/j.vaccine.2019.05.049. Epub 2019 May 21.

引用本文的文献

1
Low Measles Seropositivity in Vaccinated Children.接种疫苗儿童的麻疹血清阳性率较低。
JAMA Netw Open. 2025 Aug 1;8(8):e2529409. doi: 10.1001/jamanetworkopen.2025.29409.
2
A Nationwide Seroprevalence Study for Measles in Individuals of Fertile Age in Romania.罗马尼亚育龄人群麻疹血清流行率的全国性研究。
Antibodies (Basel). 2025 Apr 2;14(2):32. doi: 10.3390/antib14020032.
3
Seroprevalence of measles antibodies in women born between 1985 and 1999 in metropolitan city in India: a cross-sectional study.印度大城市1985年至1999年出生女性中麻疹抗体的血清流行率:一项横断面研究。

本文引用的文献

1
The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine.性别、体重指数和年龄对麻疹-腮腺炎-风疹疫苗第三剂后细胞和体液免疫应答的影响。
J Infect Dis. 2022 Dec 28;227(1):141-150. doi: 10.1093/infdis/jiac351.
2
In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis.在消除麻疹的背景下,接种疫苗后麻疹抗体水平会下降,但感染后则不会:一项系统评价与荟萃分析。
J Infect Dis. 2022 Sep 28;226(7):1127-1139. doi: 10.1093/infdis/jiac039.
3
Progress Toward Regional Measles Elimination - Worldwide, 2000-2020.
BMJ Public Health. 2024 Dec 11;2(2):e001417. doi: 10.1136/bmjph-2024-001417. eCollection 2024 Dec.
4
Oncolytic Viral Therapy in Osteosarcoma.溶瘤病毒治疗骨肉瘤。
Viruses. 2024 Jul 16;16(7):1139. doi: 10.3390/v16071139.
5
Immune Cells, Gut Microbiota, and Vaccines: A Gender Perspective.免疫细胞、肠道微生物群和疫苗:性别视角。
Cells. 2024 Mar 17;13(6):526. doi: 10.3390/cells13060526.
6
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.对于多发性硬化症患者,在开始治疗之前,采用单次剂量免疫接种活减毒疫苗策略是一种有效的选择。
Mult Scler. 2023 Dec;29(14):1841-1848. doi: 10.1177/13524585231200303. Epub 2023 Sep 20.
迈向区域消除麻疹的进展 - 全球,2000-2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1563-1569. doi: 10.15585/mmwr.mm7045a1.
4
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.10 国因新冠疫情相关干扰对麻疹、脑膜炎球菌 A 型和黄热病疫苗接种的影响。
Elife. 2021 Jun 24;10:e67023. doi: 10.7554/eLife.67023.
5
A dangerous measles future looms beyond the COVID-19 pandemic.在新冠疫情之后,危险的麻疹未来正隐隐浮现。
Nat Med. 2021 Mar;27(3):360-361. doi: 10.1038/s41591-021-01237-5.
6
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis.三价麻疹、腮腺炎和风疹疫苗的免疫原性和持久性:系统评价和荟萃分析。
Lancet Infect Dis. 2021 Feb;21(2):286-295. doi: 10.1016/S1473-3099(20)30442-4. Epub 2020 Sep 1.
7
National Update on Measles Cases and Outbreaks - United States, January 1-October 1, 2019.2019 年 1 月 1 日至 10 月 1 日美国麻疹病例和暴发的全国最新情况。
MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):893-896. doi: 10.15585/mmwr.mm6840e2.
8
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.评估加拿大安大略省麻疹人群免疫水平:加拿大免疫研究网络(CIRN)研究。
Hum Vaccin Immunother. 2019;15(12):2856-2864. doi: 10.1080/21645515.2019.1619402. Epub 2019 Jul 16.
9
Seroprevalence and durability of rubella virus antibodies in a highly immunized population.风疹病毒抗体在高度免疫人群中的血清阳性率和持久性。
Vaccine. 2019 Jun 27;37(29):3876-3882. doi: 10.1016/j.vaccine.2019.05.049. Epub 2019 May 21.
10
Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling.使用血清学数据和数学模型估算关键流行病学参数的样本量计算。
BMC Med Res Methodol. 2019 Mar 7;19(1):51. doi: 10.1186/s12874-019-0692-1.